The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Factor IX Concentrates Injection Market Research Report 2024
Synopsis
Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Factor IX Concentrates Injection market was valued at US$ 938 million in 2023 and is anticipated to reach US$ 2076 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
North American market for Factor IX Concentrates Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Factor IX Concentrates Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Factor IX Concentrates Injection include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Factor IX Concentrates Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Concentrates Injection.
The Factor IX Concentrates Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Factor IX Concentrates Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor IX Concentrates Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Factor IX Concentrates Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Factor IX Concentrates Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
The global Factor IX Concentrates Injection market was valued at US$ 938 million in 2023 and is anticipated to reach US$ 2076 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.
North American market for Factor IX Concentrates Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Factor IX Concentrates Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Factor IX Concentrates Injection include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Factor IX Concentrates Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Concentrates Injection.
The Factor IX Concentrates Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Factor IX Concentrates Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Factor IX Concentrates Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Factor IX Concentrates Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Factor IX Concentrates Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Factor IX Concentrates Injection Market Overview
1.1 Product Definition
1.2 Factor IX Concentrates Injection by Type
1.2.1 Global Factor IX Concentrates Injection Market Value Comparison by Type (2024-2030)
1.2.2 Beriplex
1.2.3 Profilnine
1.2.4 Octaplex
1.2.5 Prothromplex
1.2.6 Cofact
1.2.7 Other
1.3 Factor IX Concentrates Injection by Application
1.3.1 Global Factor IX Concentrates Injection Market Value by Application (2024-2030)
1.3.2 Hemophilia B
1.3.3 Acquired Coagulation Factor Deficiency
1.4 Global Factor IX Concentrates Injection Market Size Estimates and Forecasts
1.4.1 Global Factor IX Concentrates Injection Revenue 2019-2030
1.4.2 Global Factor IX Concentrates Injection Sales 2019-2030
1.4.3 Global Factor IX Concentrates Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Factor IX Concentrates Injection Market Competition by Manufacturers
2.1 Global Factor IX Concentrates Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Factor IX Concentrates Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Factor IX Concentrates Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Factor IX Concentrates Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Factor IX Concentrates Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Factor IX Concentrates Injection, Product Type & Application
2.7 Global Key Manufacturers of Factor IX Concentrates Injection, Date of Enter into This Industry
2.8 Global Factor IX Concentrates Injection Market Competitive Situation and Trends
2.8.1 Global Factor IX Concentrates Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Factor IX Concentrates Injection Players Market Share by Revenue
2.8.3 Global Factor IX Concentrates Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Factor IX Concentrates Injection Market Scenario by Region
3.1 Global Factor IX Concentrates Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Factor IX Concentrates Injection Sales by Region: 2019-2030
3.2.1 Global Factor IX Concentrates Injection Sales by Region: 2019-2024
3.2.2 Global Factor IX Concentrates Injection Sales by Region: 2025-2030
3.3 Global Factor IX Concentrates Injection Revenue by Region: 2019-2030
3.3.1 Global Factor IX Concentrates Injection Revenue by Region: 2019-2024
3.3.2 Global Factor IX Concentrates Injection Revenue by Region: 2025-2030
3.4 North America Factor IX Concentrates Injection Market Facts & Figures by Country
3.4.1 North America Factor IX Concentrates Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Factor IX Concentrates Injection Sales by Country (2019-2030)
3.4.3 North America Factor IX Concentrates Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Factor IX Concentrates Injection Market Facts & Figures by Country
3.5.1 Europe Factor IX Concentrates Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Factor IX Concentrates Injection Sales by Country (2019-2030)
3.5.3 Europe Factor IX Concentrates Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Factor IX Concentrates Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Factor IX Concentrates Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Factor IX Concentrates Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Factor IX Concentrates Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Factor IX Concentrates Injection Market Facts & Figures by Country
3.7.1 Latin America Factor IX Concentrates Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Factor IX Concentrates Injection Sales by Country (2019-2030)
3.7.3 Latin America Factor IX Concentrates Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Factor IX Concentrates Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Factor IX Concentrates Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Factor IX Concentrates Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Factor IX Concentrates Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Factor IX Concentrates Injection Sales by Type (2019-2030)
4.1.1 Global Factor IX Concentrates Injection Sales by Type (2019-2024)
4.1.2 Global Factor IX Concentrates Injection Sales by Type (2025-2030)
4.1.3 Global Factor IX Concentrates Injection Sales Market Share by Type (2019-2030)
4.2 Global Factor IX Concentrates Injection Revenue by Type (2019-2030)
4.2.1 Global Factor IX Concentrates Injection Revenue by Type (2019-2024)
4.2.2 Global Factor IX Concentrates Injection Revenue by Type (2025-2030)
4.2.3 Global Factor IX Concentrates Injection Revenue Market Share by Type (2019-2030)
4.3 Global Factor IX Concentrates Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Factor IX Concentrates Injection Sales by Application (2019-2030)
5.1.1 Global Factor IX Concentrates Injection Sales by Application (2019-2024)
5.1.2 Global Factor IX Concentrates Injection Sales by Application (2025-2030)
5.1.3 Global Factor IX Concentrates Injection Sales Market Share by Application (2019-2030)
5.2 Global Factor IX Concentrates Injection Revenue by Application (2019-2030)
5.2.1 Global Factor IX Concentrates Injection Revenue by Application (2019-2024)
5.2.2 Global Factor IX Concentrates Injection Revenue by Application (2025-2030)
5.2.3 Global Factor IX Concentrates Injection Revenue Market Share by Application (2019-2030)
5.3 Global Factor IX Concentrates Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Factor IX Concentrates Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CSL Behring Factor IX Concentrates Injection Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Factor IX Concentrates Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Factor IX Concentrates Injection Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Octapharma
6.3.1 Octapharma Company Information
6.3.2 Octapharma Description and Business Overview
6.3.3 Octapharma Factor IX Concentrates Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Octapharma Factor IX Concentrates Injection Product Portfolio
6.3.5 Octapharma Recent Developments/Updates
6.4 Prothya Biosolutions
6.4.1 Prothya Biosolutions Company Information
6.4.2 Prothya Biosolutions Description and Business Overview
6.4.3 Prothya Biosolutions Factor IX Concentrates Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prothya Biosolutions Factor IX Concentrates Injection Product Portfolio
6.4.5 Prothya Biosolutions Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Company Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Factor IX Concentrates Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Takeda Factor IX Concentrates Injection Product Portfolio
6.5.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Factor IX Concentrates Injection Industry Chain Analysis
7.2 Factor IX Concentrates Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Factor IX Concentrates Injection Production Mode & Process
7.4 Factor IX Concentrates Injection Sales and Marketing
7.4.1 Factor IX Concentrates Injection Sales Channels
7.4.2 Factor IX Concentrates Injection Distributors
7.5 Factor IX Concentrates Injection Customers
8 Factor IX Concentrates Injection Market Dynamics
8.1 Factor IX Concentrates Injection Industry Trends
8.2 Factor IX Concentrates Injection Market Drivers
8.3 Factor IX Concentrates Injection Market Challenges
8.4 Factor IX Concentrates Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Factor IX Concentrates Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Factor IX Concentrates Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Factor IX Concentrates Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Factor IX Concentrates Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Factor IX Concentrates Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Factor IX Concentrates Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Factor IX Concentrates Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Factor IX Concentrates Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Factor IX Concentrates Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Factor IX Concentrates Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Factor IX Concentrates Injection, Product Type & Application
Table 12. Global Key Manufacturers of Factor IX Concentrates Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Factor IX Concentrates Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Factor IX Concentrates Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Factor IX Concentrates Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Factor IX Concentrates Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Factor IX Concentrates Injection Sales Market Share by Region (2019-2024)
Table 19. Global Factor IX Concentrates Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Factor IX Concentrates Injection Sales Market Share by Region (2025-2030)
Table 21. Global Factor IX Concentrates Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Factor IX Concentrates Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Factor IX Concentrates Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Factor IX Concentrates Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Factor IX Concentrates Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Factor IX Concentrates Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Factor IX Concentrates Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Factor IX Concentrates Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Factor IX Concentrates Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Factor IX Concentrates Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Factor IX Concentrates Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Factor IX Concentrates Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Factor IX Concentrates Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Factor IX Concentrates Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Factor IX Concentrates Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Factor IX Concentrates Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Factor IX Concentrates Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Factor IX Concentrates Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Factor IX Concentrates Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Factor IX Concentrates Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Factor IX Concentrates Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Factor IX Concentrates Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Factor IX Concentrates Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Factor IX Concentrates Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Factor IX Concentrates Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Factor IX Concentrates Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Factor IX Concentrates Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Factor IX Concentrates Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Factor IX Concentrates Injection Sales Market Share by Type (2019-2024)
Table 53. Global Factor IX Concentrates Injection Sales Market Share by Type (2025-2030)
Table 54. Global Factor IX Concentrates Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Factor IX Concentrates Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Factor IX Concentrates Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Factor IX Concentrates Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Factor IX Concentrates Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Factor IX Concentrates Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Factor IX Concentrates Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Factor IX Concentrates Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Factor IX Concentrates Injection Sales Market Share by Application (2019-2024)
Table 63. Global Factor IX Concentrates Injection Sales Market Share by Application (2025-2030)
Table 64. Global Factor IX Concentrates Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Factor IX Concentrates Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Factor IX Concentrates Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Factor IX Concentrates Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Factor IX Concentrates Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Factor IX Concentrates Injection Price (US$/Unit) by Application (2025-2030)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Factor IX Concentrates Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. CSL Behring Factor IX Concentrates Injection Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Factor IX Concentrates Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Grifols Factor IX Concentrates Injection Product
Table 79. Grifols Recent Developments/Updates
Table 80. Octapharma Company Information
Table 81. Octapharma Description and Business Overview
Table 82. Octapharma Factor IX Concentrates Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Octapharma Factor IX Concentrates Injection Product
Table 84. Octapharma Recent Developments/Updates
Table 85. Prothya Biosolutions Company Information
Table 86. Prothya Biosolutions Description and Business Overview
Table 87. Prothya Biosolutions Factor IX Concentrates Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Prothya Biosolutions Factor IX Concentrates Injection Product
Table 89. Prothya Biosolutions Recent Developments/Updates
Table 90. Takeda Company Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Factor IX Concentrates Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Takeda Factor IX Concentrates Injection Product
Table 94. Takeda Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Factor IX Concentrates Injection Distributors List
Table 98. Factor IX Concentrates Injection Customers List
Table 99. Factor IX Concentrates Injection Market Trends
Table 100. Factor IX Concentrates Injection Market Drivers
Table 101. Factor IX Concentrates Injection Market Challenges
Table 102. Factor IX Concentrates Injection Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Factor IX Concentrates Injection
Figure 2. Global Factor IX Concentrates Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Factor IX Concentrates Injection Market Share by Type: 2023 & 2030
Figure 4. Beriplex Product Picture
Figure 5. Profilnine Product Picture
Figure 6. Octaplex Product Picture
Figure 7. Prothromplex Product Picture
Figure 8. Cofact Product Picture
Figure 9. Other Product Picture
Figure 10. Global Factor IX Concentrates Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Factor IX Concentrates Injection Market Share by Application: 2023 & 2030
Figure 12. Hemophilia B
Figure 13. Acquired Coagulation Factor Deficiency
Figure 14. Global Factor IX Concentrates Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Factor IX Concentrates Injection Market Size (2019-2030) & (US$ Million)
Figure 16. Global Factor IX Concentrates Injection Sales (2019-2030) & (K Units)
Figure 17. Global Factor IX Concentrates Injection Average Price (US$/Unit) & (2019-2030)
Figure 18. Factor IX Concentrates Injection Report Years Considered
Figure 19. Factor IX Concentrates Injection Sales Share by Manufacturers in 2023
Figure 20. Global Factor IX Concentrates Injection Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Factor IX Concentrates Injection Players: Market Share by Revenue in Factor IX Concentrates Injection in 2023
Figure 22. Factor IX Concentrates Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Factor IX Concentrates Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Factor IX Concentrates Injection Sales Market Share by Country (2019-2030)
Figure 25. North America Factor IX Concentrates Injection Revenue Market Share by Country (2019-2030)
Figure 26. United States Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Factor IX Concentrates Injection Sales Market Share by Country (2019-2030)
Figure 29. Europe Factor IX Concentrates Injection Revenue Market Share by Country (2019-2030)
Figure 30. Germany Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Factor IX Concentrates Injection Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Factor IX Concentrates Injection Revenue Market Share by Region (2019-2030)
Figure 37. China Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Factor IX Concentrates Injection Sales Market Share by Country (2019-2030)
Figure 45. Mexico Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Factor IX Concentrates Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Factor IX Concentrates Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Factor IX Concentrates Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Factor IX Concentrates Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Factor IX Concentrates Injection by Type (2019-2030)
Figure 56. Global Factor IX Concentrates Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Factor IX Concentrates Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Factor IX Concentrates Injection by Application (2019-2030)
Figure 59. Global Factor IX Concentrates Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Factor IX Concentrates Injection Value Chain
Figure 61. Factor IX Concentrates Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
